Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Yang H, Li V, Park SJ, Cheon SW, Lorant A, Mazumder A, Lee JY, Orlikova-Boyer B, Cerella C, Christov C, Kirsch G, Olberg DE, Bormans G, Kang HJ, Han BW, Schnekenburger M, Diederich M

Open source

DOI: 10.1186/s13148-025-01921-0
Published: 2025 Jul 16
Container: Clinical epigenetics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13148-025-01921-0,
  title = {Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.},
  author = {Yang H and Li V and Park SJ and Cheon SW and Lorant A and Mazumder A and Lee JY and Orlikova-Boyer B and Cerella C and Christov C and Kirsch G and Olberg DE and Bormans G and Kang HJ and Han BW and Schnekenburger M and Diederich M},
  year = {2025},
  journal = {Clinical epigenetics},
  doi = {10.1186/s13148-025-01921-0},
  url = {https://doi.org/10.1186/s13148-025-01921-0}
}

RIS

TY  - JOUR
TI  - Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
AU  - Yang H
AU  - Li V
AU  - Park SJ
AU  - Cheon SW
AU  - Lorant A
AU  - Mazumder A
AU  - Lee JY
AU  - Orlikova-Boyer B
AU  - Cerella C
AU  - Christov C
AU  - Kirsch G
AU  - Olberg DE
AU  - Bormans G
AU  - Kang HJ
AU  - Han BW
AU  - Schnekenburger M
AU  - Diederich M
PY  - 2025
JO  - Clinical epigenetics
DO  - 10.1186/s13148-025-01921-0
UR  - https://doi.org/10.1186/s13148-025-01921-0
ER  -

APA

H, Y., V, L., SJ, P., SW, C., A, L., A, M., JY, L., B, O., C, C., C, C., G, K., DE, O., G, B., HJ, K., BW, H., M, S., & M, D. (2025). Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.. Clinical epigenetics. https://doi.org/10.1186/s13148-025-01921-0

Source records

pubmed · retrieved 2026-09-27T08:16:46.092Z